Literature DB >> 10982793

Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax.

T H Kim1, Y Zhao, M J Barber, D K Kuharsky, X M Yin.   

Abstract

Bid, a pro-apoptosis "BH3-only" member of the Bcl-2 family, can be cleaved by caspase-8 after Fas/TNF-R1 engagement. The p15 form of truncated Bid (tBid) translocates to mitochondria and induces cytochrome c release, leading to the activation of downstream caspases and apoptosis. In the current study, we investigated the mechanism by which tBid regulated cytochrome c release in terms of its relationship to mitochondrial permeability transition and Bax, another Bcl-2 family protein. We employed an in vitro reconstitution system as well as cell cultures and an animal model to reflect the physiological environment where Bid could be functional. We found that induction of cytochrome c release by tBid was not accompanied by a permeability transition even at high doses. Indeed, inhibition of permeability transition did not suppress the activity of tBid in vitro nor could they block Fas activation-induced, Bid-dependent hepatocyte apoptosis in cultures. Furthermore, Mg(2+), although inhibiting permeability transition, actually enhanced the ability of tBid to induce cytochrome c release. We also found that tBid did not require Bax to induce cytochrome c release in vitro. In addition, mice deficient in bax were still highly susceptible to anti-Fas-induced hepatocyte apoptosis, in which cytochrome c release was unaffected. Moreover, although Bax-induced cytochrome c release was not dependent on tBid, the two proteins could function synergistically. We conclude that Bid possesses the biochemical activity to induce cytochrome c release through a mechanism independent of mitochondrial permeability transition pore and Bax.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982793     DOI: 10.1074/jbc.M003370200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Death receptors couple to both cell proliferation and apoptosis.

Authors:  Ralph C Budd
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 2.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

3.  Apoptosis-inducing factor (AIF) is targeted in IFN-α2a-induced Bid-mediated apoptosis through Bak activation in ovarian cancer cells.

Authors:  Kotaro Miyake; Joseph Bekisz; Tongmao Zhao; Christopher R Clark; Kathryn C Zoon
Journal:  Biochim Biophys Acta       Date:  2012-06-07

4.  Androgen and its receptor promote Bax-mediated apoptosis.

Authors:  Yuting Lin; John Kokontis; Fangming Tang; Bradley Godfrey; Shutsung Liao; Anning Lin; Youting Chen; Jialing Xiang
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

Review 5.  Motility, survival, and proliferation.

Authors:  William T Gerthoffer; Dedmer Schaafsma; Pawan Sharma; Saeid Ghavami; Andrew J Halayko
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

6.  Proapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancers.

Authors:  Frank A Sinicrope; Rafaela L Rego; Nathan R Foster; Stephen N Thibodeau; Steven R Alberts; Harold E Windschitl; Daniel J Sargent
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

7.  Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2.

Authors:  Vladimir Lesnikov; Nicholas Gorden; Nelson Fausto; Emily Spaulding; Jean Campbell; Howard Shulman; Robert E Fleming; H Joachim Deeg
Journal:  Apoptosis       Date:  2008-08       Impact factor: 4.677

8.  BH3-only protein bid participates in the Bcl-2 network in healthy liver cells.

Authors:  Hayato Hikita; Tetsuo Takehara; Takahiro Kodama; Satoshi Shimizu; Atsushi Hosui; Takuya Miyagi; Tomohide Tatsumi; Hisashi Ishida; Kazuyoshi Ohkawa; Wei Li; Tatsuya Kanto; Naoki Hiramatsu; Lothar Hennighausen; Xiao-Ming Yin; Norio Hayashi
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

9.  Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and -resistant human ovarian cancer cells.

Authors:  Gaetano Marverti; Alessio Ligabue; Monica Montanari; Davide Guerrieri; Matteo Cusumano; Maria Letizia Di Pietro; Leonarda Troiano; Elena Di Vono; Stefano Iotti; Giovanna Farruggia; Federica Wolf; Maria Giuseppina Monti; Chiara Frassineti
Journal:  Invest New Drugs       Date:  2009-10-16       Impact factor: 3.850

10.  Suppression of lung tumorigenesis by leucine zipper/EF hand-containing transmembrane-1.

Authors:  Soon-Kyung Hwang; Longzhen Piao; Hwang-Tae Lim; Arash Minai-Tehrani; Kyeong-Nam Yu; Youn-Cheol Ha; Chan-Hee Chae; Kee-Ho Lee; George R Beck; Jongsun Park; Myung-Haing Cho
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.